Clinical Trial Update: Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region

View source ↗

Summary

A multinational trial evaluating rivaroxaban (Xarelto) for prevention of stroke in patients with atrial fibrillation in Latin America and the EMEA region has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Status: COMPLETED